MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

Search

Omnicell Inc

Chiusa

SettoreSettore sanitario

50.25 5.97

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

47.22

Massimo

50.94

Metriche Chiave

By Trading Economics

Entrata

-177K

5.5M

Vendite

20M

311M

P/E

Media del settore

109.14

87.826

EPS

0.51

Margine di Profitto

1.758

Dipendenti

3,600

EBITDA

524K

31M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+14.23% upside

Dividendi

By Dow Jones

Utili prossimi

5 feb 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

753M

2.2B

Apertura precedente

44.28

Chiusura precedente

50.25

Notizie sul Sentiment di mercato

By Acuity

72%

28%

52 / 372 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bearish Evidence

Omnicell Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

8 gen 2026, 23:08 UTC

Acquisizioni, Fusioni, Takeovers

Rio Tinto, Glencore in Talks to Form World's Biggest Miner -- 3rd Update

8 gen 2026, 21:39 UTC

Acquisizioni, Fusioni, Takeovers

Glencore, Rio Tinto Restart Merger Talks -- 2nd Update

8 gen 2026, 20:54 UTC

Acquisizioni, Fusioni, Takeovers

Glencore, Rio Tinto Restart Merger Talks -- Update

8 gen 2026, 20:44 UTC

Acquisizioni, Fusioni, Takeovers

Glencore, Rio Tinto Restart Merger Talks

8 gen 2026, 17:05 UTC

Acquisizioni, Fusioni, Takeovers

Chinese Anta Sports Products Offers to Buy Pinault Family's Stake in Puma, Reuters Says, Citing Unnamed Sources

8 gen 2026, 16:43 UTC

I principali Market Mover

Babcock & Wilcox Shares Rise on Siemens Deal for Data Center Project

8 gen 2026, 23:44 UTC

Discorsi di Mercato

Nikkei May Rise on Weaker Yen -- Market Talk

8 gen 2026, 23:37 UTC

Discorsi di Mercato

Gold Steady, Underpinned by Geopolitical Risks -- Market Talk

8 gen 2026, 22:42 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

8 gen 2026, 22:42 UTC

Discorsi di Mercato

RBA Still Battling a Troubling Inflation Outlook, Says TD -- Market Talk

8 gen 2026, 22:30 UTC

Acquisizioni, Fusioni, Takeovers

Glencore, Rio Tinto Confirm Early Merger Talks -- Barrons.com

8 gen 2026, 21:53 UTC

Utili

These Stocks Moved the Most Today: Lockheed, Northrop, Alphabet, Applied Digital, Bloom Energy, Neogen, and More -- Barrons.com

8 gen 2026, 21:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

8 gen 2026, 21:50 UTC

Discorsi di Mercato

Auto & Transport Roundup: Market Talk

8 gen 2026, 21:10 UTC

Acquisizioni, Fusioni, Takeovers

Rio Tinto Says Current Expectation That Any Deal Would Involve Buying Glencore Via Scheme of Arrangement

8 gen 2026, 21:09 UTC

Discorsi di Mercato

Oil Rises As Trump Said to Back Russia Sanctions Bill -- Market Talk

8 gen 2026, 21:09 UTC

Acquisizioni, Fusioni, Takeovers

Rio Tinto Confirms in Talks With Glencore Over Possible Merger

8 gen 2026, 20:21 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Down Despite Inventory Draw -- Market Talk

8 gen 2026, 19:44 UTC

Discorsi di Mercato

Gold's Shine Masks Deep Drops in Canada Steel, Aluminum Exports -- Market Talk

8 gen 2026, 18:50 UTC

Discorsi di Mercato

Mexico's Industrial Production Seen Lower in November -- Market Talk

8 gen 2026, 17:48 UTC

Utili

These Stocks Are Moving the Most Today: Lockheed, Northrop, Alphabet, Applied Digital, Bloom Energy, Neogen, and More -- Barrons.com

8 gen 2026, 17:20 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

8 gen 2026, 17:20 UTC

Discorsi di Mercato

Auto & Transport Roundup: Market Talk

8 gen 2026, 17:20 UTC

Discorsi di Mercato

Health Care Roundup: Market Talk

8 gen 2026, 17:15 UTC

Discorsi di Mercato

Global Commodities Roundup: Market Talk

8 gen 2026, 16:45 UTC

Discorsi di Mercato

Goldman Lifts 1H LME Copper Forecast -- Market Talk

8 gen 2026, 16:03 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

8 gen 2026, 16:03 UTC

Discorsi di Mercato

Currency Markets Could Be Underpricing Medium-Term Risks -- Market Talk

8 gen 2026, 16:02 UTC

Discorsi di Mercato

U.S. Natural Gas Inventories Fall As Expected -- Market Talk

8 gen 2026, 15:23 UTC

Acquisizioni, Fusioni, Takeovers

Paramount Defends Its Hostile Bid for Warner -- Update

Confronto tra pari

Modifica del prezzo

Omnicell Inc Previsione

Obiettivo di Prezzo

By TipRanks

14.23% in crescita

Previsioni per 12 mesi

Media 54.2 USD  14.23%

Alto 63 USD

Basso 46 USD

Basato su 6 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Omnicell Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

6 ratings

5

Acquista

1

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

24.23 / 30.44Supporto e resistenza

A breve termine

Strong Bearish Evidence

A termine intermedio

Strong Bearish Evidence

A lungo termine

Bearish Evidence

Sentiment

By Acuity

52 / 372 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove ribassiste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat